AbbVie Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI® (Risankizumab) Subcutaneous Induction in Patients with Crohn's Disease

AbbVie (NYSE: ABBV) today announced positive topline results from the Phase 3, randomized, placebo-controlled, double-blind AFFIRM study evaluating the efficacy and safety of risankizumab (SKYRIZI®) ...
IEEE

Interactive Channel Segmentation From 2-D Seismic Images Using Deep Learning and Conditional Random Fields

Abstract: In the exploration of oil and gas reservoirs, channels are important locations for storing oil and gas, and their distribution in the subsurface is usually heterogeneous. Therefore, ...

Gallant Announces First-of-Its-Kind Partnership with MWI Animal Health to Deliver Anticipated FDA-Conditionally Approved Stem Cell Therapy into Veterinary Clinics

Gallant, an animal health biotechnology company pioneering off-the-shelf stem cell therapies for pets, today announced a landmark fulfillment agreement with MWI Animal Health (MWI), part of global ...
IEEE

Causal Temporal Neural Networks Using the Conditional Average Treatment Effect

Abstract: This paper presents a method to integrate causal inference into deep learning for time series forecasting. We consider time series for complex systems characterized by non-linear dynamics, ...